BRPI0819854A2 - Enumeração e caracterização automatizada de células de melanoma circulantes no sangue - Google Patents

Enumeração e caracterização automatizada de células de melanoma circulantes no sangue

Info

Publication number
BRPI0819854A2
BRPI0819854A2 BRPI0819854-3A BRPI0819854A BRPI0819854A2 BR PI0819854 A2 BRPI0819854 A2 BR PI0819854A2 BR PI0819854 A BRPI0819854 A BR PI0819854A BR PI0819854 A2 BRPI0819854 A2 BR PI0819854A2
Authority
BR
Brazil
Prior art keywords
characterization
melanoma cells
blood circulating
circulating melanoma
automated enumeration
Prior art date
Application number
BRPI0819854-3A
Other languages
English (en)
Inventor
Mark Carle Connelly
Galla Chandra Rao
Leon Wmm Terstappen
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of BRPI0819854A2 publication Critical patent/BRPI0819854A2/pt
Publication of BRPI0819854B1 publication Critical patent/BRPI0819854B1/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589CD45
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0819854-3A 2007-11-27 2008-10-20 Método para isolar, enriquecer e analisar células de melanoma circulantes em uma amostra de sangue BRPI0819854B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US434507P 2007-11-27 2007-11-27
US61/004,345 2007-11-27
PCT/US2008/080436 WO2009070392A1 (en) 2007-11-27 2008-10-20 Automated enumeration and characterization of circulating melanoma cells in blood

Publications (2)

Publication Number Publication Date
BRPI0819854A2 true BRPI0819854A2 (pt) 2015-06-16
BRPI0819854B1 BRPI0819854B1 (pt) 2019-06-04

Family

ID=40670042

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819854-3A BRPI0819854B1 (pt) 2007-11-27 2008-10-20 Método para isolar, enriquecer e analisar células de melanoma circulantes em uma amostra de sangue

Country Status (11)

Country Link
US (1) US20090136946A1 (pt)
EP (1) EP2225563B1 (pt)
JP (1) JP5479355B2 (pt)
KR (1) KR101604649B1 (pt)
CN (1) CN101878429B (pt)
BR (1) BRPI0819854B1 (pt)
CA (1) CA2706442C (pt)
DK (1) DK2225563T3 (pt)
IL (1) IL205864A (pt)
MX (1) MX2010005811A (pt)
WO (1) WO2009070392A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2359164A4 (en) 2008-12-10 2012-05-30 Abqmr Inc CORE MAGNETIC RESONANCE DEVICE, METHOD AND ASSOCIATED TECHNOLOGY
WO2010151109A1 (en) * 2009-06-26 2010-12-29 Erasmus University Medical Center Rotterdam Identifying circulating tumor cells (ctcs) using cd146 in breast cancers patients
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
TWI539158B (zh) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
WO2013013222A1 (en) * 2011-07-21 2013-01-24 Veridex, Llc Assay to capture and detect circulating multiple myeloma cells from blood
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
PL2972359T3 (pl) 2013-03-15 2021-03-08 Menarini Silicon Biosystems S.P.A. Wzbogacanie krążących komórek nowotworowych poprzez deplecję białych krwinek
CN103472227A (zh) * 2013-09-18 2013-12-25 上海卫恒医疗器械有限公司 一种循环肿瘤细胞检测试剂盒、配套仪器及应用
CN107850587B (zh) * 2015-05-26 2021-06-15 创新微技术公司 循环肿瘤细胞有丝分裂指数在癌症分层和诊断中的应用
MX2024007563A (es) 2021-12-17 2024-08-27 Bioaffinity Tech Inc Detección de cáncer de pulmón en etapa temprana en esputo utilizando citometría de flujo automatizada y aprendizaje automático.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
AU1585799A (en) * 1997-11-14 1999-06-07 General Hospital Corporation, The Treatment of hematologic disorders
US20010018192A1 (en) * 1998-02-12 2001-08-30 Terstappen Leon W.M.M. Labeled cells for use as an internal functional control in rare cell detection assays
BR9907852A (pt) * 1998-02-12 2000-10-24 Immunivest Corp Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes
US7029652B2 (en) * 1998-09-16 2006-04-18 The Regents Of The University Of California Method of treating tumors
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
US6222096B1 (en) * 1999-03-01 2001-04-24 Stine Biotechnology Promoter and construct for plant transformation
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
ATE488529T1 (de) * 1999-07-28 2010-12-15 Genentech Inc Zusammensetzungen und verfahren zur behandlung von tumoren
CA2404431C (en) * 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c in the detection of stomach and esophageal cancers
CN1516597A (zh) * 2000-10-13 2004-07-28 Ī��ʲ��ѧ 胸腺功能的诊断指示指标
US7223596B2 (en) * 2003-09-05 2007-05-29 Wisconsin Alumni Research Foundation Malignant endothelial cell line and uses thereof in models for angiogenesis
WO2006130737A1 (en) * 2005-06-02 2006-12-07 Immunivest Corporation A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
US20070037173A1 (en) * 2005-08-12 2007-02-15 Allard Jeffrey W Circulating tumor cells (CTC's): early assessment of time to progression, survival and response to therapy in metastatic cancer patients

Also Published As

Publication number Publication date
CN101878429A (zh) 2010-11-03
DK2225563T3 (en) 2015-02-09
WO2009070392A1 (en) 2009-06-04
US20090136946A1 (en) 2009-05-28
CA2706442A1 (en) 2009-06-04
KR101604649B1 (ko) 2016-03-18
MX2010005811A (es) 2010-06-09
CN101878429B (zh) 2015-05-20
JP5479355B2 (ja) 2014-04-23
EP2225563A1 (en) 2010-09-08
HK1148348A1 (en) 2011-09-02
KR20100101109A (ko) 2010-09-16
IL205864A (en) 2016-12-29
JP2011505012A (ja) 2011-02-17
CA2706442C (en) 2017-07-11
EP2225563A4 (en) 2011-11-16
HK1148068A1 (en) 2011-08-26
IL205864A0 (en) 2010-11-30
BRPI0819854B1 (pt) 2019-06-04
EP2225563B1 (en) 2015-01-21

Similar Documents

Publication Publication Date Title
BRPI0819854A2 (pt) Enumeração e caracterização automatizada de células de melanoma circulantes no sangue
PT2257155T (pt) Criopreservação de células e tecidos biológicos
PL2027470T3 (pl) Oznaczenie krążących komórek nowotworowych
BRPI0809902A2 (pt) Métodos de avaliar células e culturas celulares
BRPI0921822A2 (pt) composição compreendendo polímero e enzima
IL254144A0 (en) Methods for reprogramming cells and uses thereof
EP2227812A4 (en) MEMORY CELL READING
BRPI0818741A2 (pt) equipamento e método de avaliação da presença de microorganismos no sangue
BR112012004986A2 (pt) monitoramento e rastreamento atividade atlética
EP2401357A4 (en) HOST CELLS AND METHOD FOR THEIR USE
EP2291876A4 (en) THIN FILM BATTERIES AND METHOD FOR THE PRODUCTION THEREOF
EP2097538A4 (en) TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
EP2253009A4 (en) LOW TEMPERATURE PLASMA PROBE AND METHODS OF USE
EP2401376A4 (en) TRANSPOSON PIGGYBAC VARIANTS AND METHODS OF USE
IT1390860B1 (it) Friggitrice e procedimento di cottura
DK2562248T3 (da) Differentiering af humane embryonale stamceller
SI2166882T1 (sl) Podpora aktivnostim vsakdanjega življenja
DK2303072T3 (da) Tæppe og relaterede produkter samt fremstilling af samme
EP2437052A4 (en) BIOSENSOR AND USE THEREOF
DE112007000789A5 (de) Verwendung von Bora-tetraazepentalenen
DK2107373T3 (da) Analysechip og analysefremgangsmåde
EP2263079A4 (en) SIMULTANEOUS ELECTROCHEMICAL DETECTION OF SEVERAL IONS OF HEAVY METALS IN A LIQUID
EP2254530A4 (en) SUBSEQUENT STENTS AND MANUFACTURING PROCESS
BRPI0817199A2 (pt) Identificaçãob e isolamento de células fetais e ácido nucleico
EP2333050A4 (en) IPS CELLS FROM B-CELLS AND ITS APPLICATION

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/06/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/06/2019, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2536 DE 13-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.